Five healthtech firms selected for Tech Nation's Upscale 5.0 programme
Five out of Tech Nation’s 30 selected companies for joining the Upscale 5.0 programme are from healthcare and life sciences backgrounds.
The companies are:
Eagle Genomics - Cambridge
Eagle Genomics’ uses machine learning to transform raw data into actionable insights that drive scientific decision making. Improving brand perception and research and development processes, Eagle Genomics’ unique expertise gives insights that enable quick assessment of product potential, mitigate risks and reduces time to market.
Anthony Finbow, founder & CEO, Eagle Genomics said: "We are delighted to have been selected to join the Tech Nation Upscale programme. Eagle Genomics is poised to grow significantly in the next year and as we rapidly scale in response to customer demand for our microbiome knowledge discovery platform, we look forward to navigating the challenges and maximising the opportunity with the support of the programme and members of our pioneering cohort community.”
Florence - London
Florence is the marketplace for flexible staffing in the care sector. Florence aims to fill care home vacancies with the perfect workers, whilst nurses and carers are empowered to take control of their working lives.
Charles Armitage, co-founder & CEO, Florence said: “We're incredibly excited to be part of Upscale 5.0 this year. The programme has some great alumni and we're excited to join the cohort of the UK's most promising tech scale ups. It will be great to spend time working with and learning from other leadership teams and scale coaches. We think Upscale will be an important stepping stone on our mission to be the market leading staffing platform for care.”
Kheiron Medical - London
Helping doctors find breast cancer earlier and more accurately, Kheiron Medical works with radiologists, and uses data and machine learning to build products that help breast radiologists in their daily practice.
Neurovalens - Belfast
Aiming to transform the world of neurology, Neurovalens wants to treat global neurological health issues by influencing the brain and nervous system using safe and non-invasive technology. This technology aims to replace drugs as the first-line treatments for obesity, diabetes, insomnia and anxiety.
Jason McKeown, co-founder & CEO, Neurovalens said: “I am delighted that Neurovalens has been selected for the Tech Nation Upscale programme, especially as we are the only Northern Irish company to have been invited to take part. Neurovalens has grown rapidly so this programme comes at an extremely important time for us as we expand into key global markets while also developing our medical R&D pathways. We applied to take part in the Upscale programme to help us navigate the exciting next phase of our journey and we are really looking forward to sharing knowledge and learning from the other incredible leading UK scaleups.”
Thriva - London
Thriva helps you find out what's happening inside your body with a finger-prick blood test. Samples are reviewed by an NHS approved lab, and a doctor walks you through your results, giving personalised advice on your health. Regular testing enables customers to keep track of how their lifestyle decisions actually affect them internally over time.